Craig Shimasaki, Moleculera Labs

Craig Shimasaki, Moleculera Labs

Date(s) - August 16, 2017
11:30 am-1:00 pm

Devon Tower, 50th Floor

$50 for nonmembers
$35 for members

Craig Shimasaki, president and CEO of Moleculera Labs, will be our speaker in August.

About Craig Shimasaki

Craig Shimasaki is a biotechnology industry professional with over 30 years of experience. He is co-founder of three biotech companies, one which was taken public.

He has experience with all aspects of start-up to mid-size biotechnology company issues, including establishing company, licensing technology and IP, virtual companies, business model selection, raising capital, product development issues and strategies (molecular testing, medical device, biologics), technical and scientific product development problem-solving, regulatory, clinical testing, marketing and branding, employee development, organizational design.

About Moleculera Labs

Moleculera Labs is a pioneer in developing and offering advanced testing services that assist physicians in identifying whether an individual’s neurologic and/or psychiatric symptoms could be caused by an autoimmune dysfunction. Obsessive compulsive disorder (OCD), tics, anxiety, attention deficit hyperactivity disorder (ADHD), and sometimes behaviors associated with Autism Spectrum Disorders have been found to be caused by a treatable autoimmune condition, triggered by common infections.